AUPH icon

Aurinia Pharmaceuticals

64 hedge funds and large institutions have $113M invested in Aurinia Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership:

less funds holding

Funds holding:

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

79% less call options, than puts

Call options by funds: $595K | Put options by funds: $2.79M

Holders
64
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$595K
Puts
$2.79M
Net Calls
Net Calls Change

Top Buyers

1 +$1.69M
2 +$1.24M
3 +$1.21M
4
PC
Polar Capital
United Kingdom
+$1.04M
5
Goldman Sachs
Goldman Sachs
New York
+$246K

Top Sellers

1 -$6.08M
2 -$2.43M
3 -$2.27M
4
AIC
AWM Investment Company
New York
-$1.61M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.1M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$25M
2
$23.8M
3
$13M
4
$8.64M
5
$6.45M
6
$6.3M
7
$5.42M
8
$3.25M
9
$3.15M
10
$2.99M
11
$1.56M
12
$1.35M
13
$1.31M
14
$1.21M
15
$962K
16
$821K
17
$810K
18
$762K
19
$680K
20
$612K
21
$599K
22
$493K
23
$486K
24
$285K
25
$264K